Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

3 Horrendous Health-Care Stocks This Week

By Keith Speights - Mar 1, 2014 at 7:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

February's over -- and investors of these horrendous health-care stocks of the week just might be saying "good riddance." Here's why.

Another month in 2014 has drawn to a close -- as has another week of horrendous performances by several health-care stocks. February is the shortest month of the year, but its final week proved to be quite a long one for some investors.

One of this week's big losers announced a secondary share offering that will lead to dilution of its stock. Another felt the brunt of allegations by a prominent short seller. And the third of our worst-performing companies did it the old-fashioned way -- by disappointing investors with its quarterly results.

Which companies made this week's list of horrendous health-care stocks? Find out by watching the following slideshow.

 

 
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Ampio Pharmaceuticals, Inc. Stock Quote
Ampio Pharmaceuticals, Inc.
AMPE
$1.01 (-5.14%) $0.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
640%
 
S&P 500 Returns
139%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/03/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.